Aibeimei® is the commercial brand name for document use only. It is a highly selective α2-adrenoceptor agonist. It exerts sedative and anxiolytic effects by activating central α2 receptors.
Main Indications
For the sedation of adult patients who need non-intubation procedural sedation.
Clinical Research
Clinical trials demonstrated that intranasal dexmedetomidine provides satisfactory sedation without significant respiratory depression. It achieves sedation within 30–45 minutes after nasal administration and has a favourable safety profile for short procedures.
Common Side Effects
Bradycardia, hypotension, dry mouth;
Other common reactions: headache, nausea. Rare serious adverse events include severe bradycardia, atrioventricular block and hypersensitivity.
Approval Status in China
Drug Aibeimei® (Dexmedetomidine Hydrochloride Nasal Spray) was officially approved for marketing in China in 2023, with the specification of 1ml:500μg, 1 bottle per box. It is currently a prescription drug.
Buy Aibeimei (Dexmedetomidine Hydrochloride Nasal Spray) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
